AT387771B - Verfahren zur herstellung von neuen oxazolidinen - Google Patents

Verfahren zur herstellung von neuen oxazolidinen

Info

Publication number
AT387771B
AT387771B AT0355384A AT355384A AT387771B AT 387771 B AT387771 B AT 387771B AT 0355384 A AT0355384 A AT 0355384A AT 355384 A AT355384 A AT 355384A AT 387771 B AT387771 B AT 387771B
Authority
AT
Austria
Prior art keywords
oxazolidines
producing new
producing
new
new oxazolidines
Prior art date
Application number
AT0355384A
Other languages
English (en)
Other versions
ATA355384A (de
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH6070/83A external-priority patent/CH655931A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ATA355384A publication Critical patent/ATA355384A/de
Application granted granted Critical
Publication of AT387771B publication Critical patent/AT387771B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT0355384A 1983-11-10 1984-11-09 Verfahren zur herstellung von neuen oxazolidinen AT387771B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6070/83A CH655931A5 (en) 1983-11-10 1983-11-10 Oxazolidines
CH449984 1984-09-20

Publications (2)

Publication Number Publication Date
ATA355384A ATA355384A (de) 1988-08-15
AT387771B true AT387771B (de) 1989-03-10

Family

ID=25695620

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0355384A AT387771B (de) 1983-11-10 1984-11-09 Verfahren zur herstellung von neuen oxazolidinen

Country Status (22)

Country Link
US (2) US4743604A (de)
AT (1) AT387771B (de)
AU (1) AU576531B2 (de)
BE (1) BE900983A (de)
CA (1) CA1249992A (de)
DE (1) DE3438411A1 (de)
DK (1) DK520584A (de)
ES (1) ES8606863A1 (de)
FI (1) FI844152L (de)
FR (1) FR2554814B1 (de)
GB (1) GB2149405B (de)
HU (1) HU193465B (de)
IL (1) IL73427A (de)
IT (1) IT1177033B (de)
LU (1) LU85631A1 (de)
MC (1) MC1641A1 (de)
NL (1) NL8403308A (de)
NO (1) NO844501L (de)
NZ (1) NZ210105A (de)
PH (1) PH22462A (de)
PT (1) PT79485B (de)
SE (1) SE463099B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009661A1 (en) * 1987-06-10 1988-12-15 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
FI892341A (fi) * 1988-06-10 1989-12-11 Hoffmann La Roche Propanolaminderivat.
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
SK111195A3 (en) * 1994-09-13 1997-06-04 Sandoz Technology Ltd Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
US8036727B2 (en) * 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
EP1874178A4 (de) 2005-04-13 2009-12-09 Glucolight Corp Verfahren zur datenreduzierung und kalibrierung eines blutzuckermonitors auf oct-basis
WO2009111542A2 (en) 2008-03-04 2009-09-11 Glucolight Corporation Methods and systems for analyte level estimation in optical coherence tomography
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA979912A (en) * 1970-06-22 1975-12-16 Frederic P. Hauck Tetrahydronaphthyloxyaminopropanols and related compounds
GB1301134A (en) * 1970-07-18 1972-12-29 Pfizer Ltd SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES

Also Published As

Publication number Publication date
IT8423307A0 (it) 1984-10-25
NL8403308A (nl) 1985-06-03
GB8428335D0 (en) 1984-12-19
IL73427A0 (en) 1985-02-28
FI844152A0 (fi) 1984-10-22
BE900983A (fr) 1985-05-06
IL73427A (en) 1988-02-29
GB2149405A (en) 1985-06-12
HUT36103A (en) 1985-08-28
NZ210105A (en) 1988-10-28
ES8606863A1 (es) 1986-05-01
DE3438411A1 (de) 1985-05-30
IT1177033B (it) 1987-08-26
US4743604A (en) 1988-05-10
DK520584A (da) 1985-05-11
LU85631A1 (fr) 1986-06-04
NO844501L (no) 1985-05-13
CA1249992A (en) 1989-02-14
GB2149405B (en) 1987-07-01
SE463099B (sv) 1990-10-08
HU193465B (en) 1987-10-28
US4871755A (en) 1989-10-03
SE8405632L (sv) 1985-05-11
ES537487A0 (es) 1986-05-01
ATA355384A (de) 1988-08-15
FR2554814B1 (fr) 1988-03-11
MC1641A1 (fr) 1986-01-09
AU576531B2 (en) 1988-09-01
FI844152L (fi) 1985-05-11
SE8405632D0 (sv) 1984-11-09
DK520584D0 (da) 1984-11-01
AU3527584A (en) 1985-05-16
PH22462A (en) 1988-09-12
FR2554814A1 (fr) 1985-05-17
IT8423307A1 (it) 1986-04-25
PT79485B (en) 1987-01-13
PT79485A (en) 1984-12-01

Similar Documents

Publication Publication Date Title
AT377524B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
AT382612B (de) Verfahren zur herstellung von neuen arylcyclobutylalkylaminen
AT383596B (de) Verfahren zur herstellung von neuen thiazolidin-derivaten
AT387771B (de) Verfahren zur herstellung von neuen oxazolidinen
AT384017B (de) Verfahren zur herstellung von neuen hydroxyaminoestern
ATA125383A (de) Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen
ATA206483A (de) Verfahren zur herstellung von neuen mitosanderivaten
AT382638B (de) Verfahren zur herstellung von neuen trehaloselipiden
ATA5985A (de) Verfahren zur herstellung von neuen 8alpha-acylaminoergolinen
AT386199B (de) Verfahren zur herstellung von neuen 2-piperazinopyrimidinen
ATA404284A (de) Verfahren zur herstellung von neuen gonadoliberin-derivaten
AT386828B (de) Verfahren zur herstellung von neuen acylaminomitosanen
AT385035B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT384226B (de) Verfahren zur herstellung von neuen 4'-halogenanthracyclinglykosiden
ATA258985A (de) Verfahren zur herstellung von neuen substituierten 7-oxomitosanen
ATA279784A (de) Verfahren zur herstellung von neuen 2-aminomethyl-2-penem-verbindungen
AT385509B (de) Verfahren zur herstellung von neuen mitosanverbindungen
ATA106084A (de) Verfahren zur herstellung von neuen gonadoliberin-derivaten
AT387385B (de) Verfahren zur herstellung von neuen substituierten 1-pyridyloxy-3-indolylalkylamino-2-propanolen
AT384214B (de) Verfahren zur herstellung von neuen mercaptoacylcarnitinen
ATA72484A (de) Verfahren zur herstellung von neuen benzamid-derivaten
ATA52285A (de) Verfahren zur herstellung von neuen diazepinoindolen
AT381939B (de) Verfahren zur herstellung von neuen azaspiroalkandionen
AT378776B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
AT386410B (de) Verfahren zur herstellung von neuen ergolinderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee